Abstract: An example system for microvascular assessment of a patient can include: a fundus imaging device including: a camera configured to capture one or more images of an eye of the patient; and at least one light source; and a microvascular assessment computing device including: a processor; and memory encoding instructions which, when executed by the processor, cause the system to: activate the light source to direct light at a fundus of the eye of the patient; capture, with the camera, one or more images of the fundus of the patient, the fundus comprising a plurality of blood vessels; and analyze with the microvascular assessment computing device, the one or more images to determine a microvasculature health index for the patient.

Abstract: A system for taking inventory over a wide area includes a database. The database stores a geofenced area divided into two or more waypoints and a route defined as path within the geofenced area across at least two waypoints. At least one mobile asset is disposed at a position in a yard corresponding to the at least one waypoint. The mobile asset has a readable tag having information about the asset thereon. An aerial vehicle having a tag reader flies along the route within the geofenced area for communicating with each tag along a route, reading the information and storing the information read from each tag.

Abstract: A medical diagnostic device (100) in different embodiments uses a headband (204) and a beanie cap (304) configured to be affixed about the head of a subject for conducting measurements for diagnosing whether the subject is at risk of a concussion. A transducer (302) determines magnitude of impact on the head of the subject provides deceleration information associated with magnitude of the force via a pressure waveform. An accelerometer (402) in connectivity with a gyroscope (602) provide directional and angular information to determine probability of risk of a concussion. Bluetooth (404 or WiFi (406) connectivity enable different transmission modes of output signals from device (100) to device capable of performing the calculated metrics and providing a digital putout.

Abstract: Methods, systems and devices for using a LED lighting system to communicate an emergency, indicate a route/pathway and illuminate an area using an existing leaky feeder communications system. The LED lighting system is powered by and may be controlled by the leaky feeder communications system that delivers 2-way communications and data. The LED lighting may be used as area wall location lighting, directional pathway indication, and area illumination. Control of the lighting system may be localized or remotely activated through hard wire or wireless connections. The system may controls dimming, pulsing, brightness, sequencing, and changing LED color.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: Methods, systems and devices for using a LED lighting system to communicate an emergency, indicate a route/pathway and illuminate an area using an existing leaky feeder communications system. The LED lighting system is powered by and may be controlled by the leaky feeder communications system that delivers 2-way communications and data. The LED lighting may be used as area wall location lighting, directional pathway indication, and area illumination. Control of the lighting system may be localized or remotely activated through hard wire or wireless connections. The system may controls dimming, pulsing, brightness, sequencing, and changing LED color.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A method for measuring reactive hyperemia in a subject is disclosed. The method includes performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve, performing a second segmental cuff plethysmography to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve, and calculating an area between the baseline and the hyperemic curves. The size of the area can be used as an indication of endothelial dysfunction (ED) and ED-related diseases.

Abstract: A system for gas-liquid separation in electrolysis processes is provided. The system includes a first compartment having a liquid carrier including a first gas therein and a second compartment having the liquid carrier including a second gas therein. The system also includes a gas-liquid separator fluidically coupled to the first and second compartments for separating the liquid carrier from the first and second gases.